We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
-17.54%
1 Year Est. Return
+128.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$84M
AUM Growth
-$18.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$68.7M 81.77%
1,047,557
KYMR icon
2
Kymera Therapeutics
KYMR
$8.94B
$12.5M 14.88%
457,059
SEER icon
3
Seer Inc
SEER
$120M
$1.38M 1.64%
816,375
RLYB icon
4
Rallybio
RLYB
$85.8M
$494K 0.59%
94,335
XLO icon
5
Xilio Therapeutics
XLO
$60.3M
$484K 0.58%
47,696
CARM
6
DELISTED
Carisma Therapeutics
CARM
$223K 0.27%
718,332
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
$121K 0.14%
12,438
STRO icon
8
Sutro Biopharma
STRO
$421M
$114K 0.14%
17,500

Similar funds

AJU IB Investment Company's Q1 2025 Portfolio in Review

As of Q1 2025, AJU IB Investment Company held 8 positions worth $84M, down 18% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. AJU IB Investment Company opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's ten largest holdings make up 100% of its $84M portfolio in Q1 2025.
  • AJU IB Investment Company opened 0 new positions and closed 0 in Q1 2025.
  • AJU IB Investment Company's portfolio value fell 18% quarter-over-quarter to $84M.

Based on AJU IB Investment Company's 13F filing for Q1 2025, filed 8 Apr 2025.